Benjamin Izar, MD
Enriched profileVivian and Seymour Milstein Family Associate Professor of Medicine · Columbia University Vagelos College of Physicians and Surgeons
Benjamin Izar is Vivian and Seymour Milstein Family Associate Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Benjamin Izar, MD, is Vivian and Seymour Milstein Family Associate Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 6 companies, 8 NIH-funded awards (2019–2026).
- Top research focus: Liposarcoma
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Director
Human Immune Monitoring Core
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →izarlab.com ↗ - Listed investigator
ATX-101 trial in dedifferentiated liposarcoma and leiomyosarcoma (listing shows 'B. Benjamin Izar'; role not fully explicit)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ctv.veeva.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
Sponsor: Benjamin Izar
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas
Sponsor: Columbia University
Industry payments
Updated 13 Nov 2026
6 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Pharming Healthcare, Inc.Program year20252 payments
- Immunocore LimitedProgram year20255 payments
- GlaxoSmithKline, LLC.Program year20241 payment
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Gabapentinoids100%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
8 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Systematic variant-to-pathway, phenotype, and precision treatment response evaluation in genetic disorders of the immune system (GDIS)
Columbia University Health Sciences
FY2026$821,367R01AI199896 - Multi-cellular interactions defining the human brain metastatic niche
Columbia University Health Sciences
FY2026$692,427R01CA280414 - Restoring anti-tumor immunity in chromosomally unstable tumors
Columbia University Health Sciences
FY2026$681,818R01CA312637
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/benjamin-izar-3833ab98
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Doximity
doximity.com/pub/benjamin-izar-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
doctors.columbia.edu/us/ny/new-york/benjamin-izar-md-phd-161-fort-washington-avenue
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Other
systemsbiology.columbia.edu/faculty/benjamin-izar-0/pmg-people
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →systemsbiology.columbia.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
PhD
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - MD/PhD
Justus Liebig University, Giessen, Germany (summa cum laude)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Association for Cancer Research
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Member
American Society of Clinical Oncology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Member
Society for Immunotherapy of Cancer
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Member
Society for Melanoma Research
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- Velocity Fellow2020verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sitc.sitcancer.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →systemsbiology.columbia.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →v.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- Tumor Biology and Microenvironment Program
Herbert Irving Comprehensive Cancer Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Media & interviews
press, podcasts and appearances- TargetedOnc video discussion: unmet needs in melanoma
drug resistance and brain and liver metastases
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Liebmann, MD
Columbia University Vagelos College of Physicians and Surgeons
Elaine Wan, MD
Columbia University Vagelos College of Physicians and Surgeons
Olajide Williams, MD
Columbia University Vagelos College of Physicians and Surgeons
Murray Brennan, MD
Memorial Sloan Kettering Cancer Center
Cristina Antonescu, MD
Memorial Sloan Kettering Cancer Center
George Demetri, MD
Dana-Farber Cancer Institute; Professor of Medicine
Jason Hornick, MD
Brigham and Women's Hospital